Analysis of non-dispensing pharmacists in general practice clinics
Assessing the proposed policy
Deloitte Access Economics was commissioned by the Australian Medical Association to analyse the financial impact of a proposed policy to integrate non-dispensing pharmacists into general practice clinics.
The policy will provide financial incentives to general practice clinics to hire a non-dispensing pharmacist, who will share current drug information with doctors and practice staff, respond to medicine queries, increase practice efficiency and free up general practitioners’ time, deliver patient-directed services, and perform practice based quality assurance activities.
The aim of the policy is to improve the quality of primary healthcare by increasing compliance and persistence with medication regimens, reduce the level and severity of adverse drug events, optimise the management of long-term conditions, and reduce the burden on the Pharmaceutical Benefits Scheme that arises from overprescribing of medicines.